Management of acute urinary retention

BJU International

Volumn 97, Issue SUPPL. 2, 2006, Pages 16-20

  Fitzpatrick, John M ^a   Kirby, Roger S ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b Prostate Centre   (United Kingdom)

Author keywords

Acute urinary retention; BPH; Progression

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; PHENOXYBENZAMINE; PHENTOLAMINE; PLACEBO; TAMSULOSIN; TERAZOSIN;

ACUTE DISEASE; ANTIGEN DETECTION; BACTERIURIA; BLADDER ASPIRATION; BLOOD LEVEL; CARCINOGENICITY; CATHETER INFECTION; CATHETER REMOVAL; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; DIZZINESS; ELECTIVE SURGERY; EMERGENCY SURGERY; EXPERIMENTAL RAT; HEMATURIA; HUMAN; HYPOTENSION; MORBIDITY; NONHUMAN; PEROPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RESIDUAL URINE; REVIEW; SEPTICEMIA; SURGICAL MORTALITY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URINE CATHETER; URINE INCONTINENCE; URINE RETENTION; VALIDATION STUDY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROSTATECTOMY; PROSTATIC HYPERPLASIA; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 33644818269     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06100.x     Document Type: Review

References (34)

1. Emberton M Anson K. Acute urinary retention in men: an age old problem BMJ 1999 318 921 5
2. Jacobsen SJ Jacobson DJ Girman CJ et al. Natural history of prostatism: risk factors for acute urinary retention J Urol 1997 158 481 7
3. Pickard R Emberton M Neal DE The management of men with acute urinary retention. National Prostatectomy Audit Steering Group Br J Urol 1998 81 712 20
4. Mebust WK Holtgrewe HL Cockett AT Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients J Urol 1989 141 243 7
5. Thomas K Oades G Taylor-Hay C Kirby RS. Acute urinary retention: what is the impact on patients' quality of life? BJU Int 2005 95 72 6
6. Choong S Emberton M. Acute urinary retention BJU Int 2000 85 186 201
7. Spiro LH Labay G Orkin LA. Prostatic infarction. Role in acute urinary retention Urology 1974 3 345 7
8. Anjum I Almed M Azzopardi A Mufti GR. Prostatic infarction/infection in acute urinary retention secondary to benign prostatic hyperplasia J Urol 1998 160 792 3
9. Tuncel A Uzun B Eruyar T Karabulut E Seckin S Atan A. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention? Eur Urol 2005 48 277 84
10. Armitage J Emberton M. Is it time to reconsider the role of prostatic inflammation in the pathogenesis of lower urinary tract symptoms? BJU Int 2005 96 745 6
11. Murray K Massey A Feneley RC. Acute urinary retention - a urodynamic assessment Br J Urol 1984 56 468 73
12. Desgrandchamps F De la Taille A Doublet J Management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia BJU Int 2006 97 727 33
13. Roehrborn CG Bruskewitz R Nickel GC et al. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group Eur Urol 2000 37 528 36
14. Elhilali M Vallancien G Emberton M et al. Management of acute urinary retention (AUR) in patients with BPH. a worldwide comparison J Urol 2004 171 Suppl. 407 A1544
15. Manikandan R Srirangam SJ O'Reilly PH CollinsGN. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey BJU Int 2004 93 84 8
16. Horgan AF Prasad B Waldron DJ O'Sullivan DC. Acute urinary retention. Comparison of suprapubic and urethral catheterization Br J Urol 1992 70 149 51
17. Taube M Gajraj H. Trial without catheter following acute retention of urine Br J Urol 1989 63 180 2
18. Hastie KJ Dickinson AJ Ahmad R Moisey CU. Acute retention of urine: is trial without catheter justified? J R Coll Surg Edinb 1990 35 225 7
19. Djavan B Chariat S Omar M et al. Does prolonged catheter drainage improve the chance of recovering voluntary voiding after acute urinary retention? Eur Urol 1998 33 Suppl. 110 A437
20. Caine M Raz S Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck Br J Urol 1975 47 193 202
21. Chan PS Wong WS Chan LW et al. Can terazosin (alpha-blocker) relieve acute urinary retention and obviate the need for indwelling urinary catheter Br J Urol 1996 77 Suppl 7 A26
22. McNeill SA Daruwala PD Mitchell ID. Shearer MG Hargreave TB. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled trial BJU Int 1999 84 622 7
23. Bowden E Hall S Foley SJ et al. Tamsulosin in the treatment of urinary retention: a prospective, placebo-controlled trial BJU Int 2001 88 Suppl. 77 Abstract P148
24. Shah T Palit V Biyani S Elmasry Y Puri R Flannigan GM. Randomized, placebo controlled double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention Eur Urol 2002 42 329 32
25. Lucas MG Stephenson TP Nargund V. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia BJU Int 2005 95 354 7
26. McNeill SA. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction Eur Urol 2004 45 325 32
27. McNeill SA Hargreave TB Members of the ALFAUR Study Group Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention J Urol 2004 171 2316 20
28. Cravens DD Zweig S. Urinary catheter management Am Fam Physician 2000 61 369 76
29. McNeill SA Hargreave TB Roehrborn CG ALFAUR Study Group Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study Urology 2005 65 83 90
30. Breum L Klarskov P Munck LK Nielsen TH Nordestgaard AG. Significance of acute urinary retention due to intravesical obstruction Scand J Urol Nephrol 1982 16 21 4
31. Klarskov P Andersen JT Asmussen CF et al. Symptoms and signs predictive of the voiding pattern after acute urinary retention in men Scand J Urol Nephrol 1987 21 23 8
32. Roehrborn CG McConnell JD Lieber M et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia Urology 1999 53 473 80
33. Roehrborn CG Kaplan SA Lee MW et al. Baseline post-void residual urine volume as a predictor of urinary outcomes in men with BPH in the MTOPS study J Urol 2005 173 Suppl. 443 A1638
34. Emberton M Elhilali M Matzkin H et al. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily Urology 2005 66 316 22